Phase I trial of ITI 007 in volunteers

Trial Profile

Phase I trial of ITI 007 in volunteers

Phase of Trial: Phase I

Latest Information Update: 22 Dec 2009

At a glance

  • Drugs Lumateperone (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Intra-Cellular Therapies
  • Most Recent Events

    • 22 Dec 2009 Status changed from recruiting to completed according to an Intra-Cellular Therapies media release.
    • 16 Jan 2009 Status changed from not yet recruiting to recruiting.
    • 29 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top